Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder

NCT02044094 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Buprenorphine
DRUG: buprenorphine and naloxone
DRUG: hydromorphone
DRUG: placebo

Sponsor

Indivior Inc.